TXTM (ProText Mobility) Market Cap: $43.96 Mil (As of Jun. 26, 2026)


What is ProText Mobility Market Cap?

ProText Mobility TXTM Market Cap is $43.96 Mil as of Jun. 26, 2026.

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). ProText Mobility's share price for the quarter that ended in Sep. 2014 was $0.0002. ProText Mobility's Shares Outstanding (EOP) for the quarter that ended in Sep. 2014 was 643.98 Mil. Therefore, ProText Mobility's market cap for the quarter that ended in Sep. 2014 was $0.13 Mil.

ProText Mobility's quarterly market cap declined from Mar. 2014 ($0.29 Mil) to Jun. 2014 ($0.16 Mil) and declined from Jun. 2014 ($0.16 Mil) to Sep. 2014 ($0.13 Mil).

ProText Mobility's annual market cap declined from Dec. 2011 ($3.42 Mil) to Dec. 2012 ($0.47 Mil) and declined from Dec. 2012 ($0.47 Mil) to Dec. 2013 ($0.14 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. ProText Mobility's Enterprise Value for Today is $43.96 Mil.


ProText Mobility  (OTCPK:TXTM) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


ProText Mobility Market Cap Related Terms


ProText Mobility Market Cap Historical Data

* Premium members only.

The historical data trend for ProText Mobility's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ProText Mobility Market Cap Chart

ProText Mobility Annual Data
Trend Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.94 16.29 3.42 0.47 0.14

ProText Mobility Quarterly Data
Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.48 0.14 0.29 0.16 0.13

TXTM vs DRSV, YPPN, CYBF: Market Cap Comparison

For the Biotechnology subindustry, ProText Mobility's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ProText Mobility Market Cap vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ProText Mobility's Market Cap distribution charts can be found below:

* The bar in red indicates where ProText Mobility's Market Cap falls into.



ProText Mobility Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

ProText Mobility's Market Cap for the fiscal year that ended in Dec. 2013 is calculated as

Market Cap (A: Dec. 2013 )=Share Price (A: Dec. 2013 )*Shares Outstanding (EOP) (A: Dec. 2013 )
=$0.08*1.734
=$0.14

ProText Mobility's Market Cap for the quarter that ended in Sep. 2014 is calculated as

Market Cap (Q: Sep. 2014 )=Share Price (Q: Sep. 2014 )*Shares Outstanding (EOP) (Q: Sep. 2014 )
=$0.0002*643.975
=$0.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Market Cap →
What does a Market Cap of $43.96 Mil mean?
ProText Mobility (TXTM) has a Market Cap of $43.96 Mil as of Jun. 26, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on ProText Mobility and its competitors.
Is ProText Mobility's Market Cap too high?
ProText Mobility's current Market Cap is $43.96 Mil. The Biotechnology industry median Market Cap is 113.83. ProText Mobility's value of $43.96 Mil is 61.4% below this industry median.
How does ProText Mobility's Market Cap compare to DRSV and YPPN?
ProText Mobility's Market Cap of $43.96 Mil can be compared against companies in the Biotechnology industry. The industry median Market Cap is 113.83. ProText Mobility's value of $43.96 Mil is 61.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 113.83, based on 1,431 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ProText Mobility's current Market Cap of $43.96 Mil is 61.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on ProText Mobility and its competitors. For the Biotechnology industry, the median Market Cap is 113.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ProText Mobility's current Market Cap is $43.96 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ProText Mobility stock overvalued right now?
ProText Mobility (TXTM) has a current Market Cap of $43.96 Mil. The current Market Cap is $43.96 Mil and 61.4% below the Biotechnology industry median of 113.83. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For ProText Mobility (TXTM), the current Market Cap is $43.96 Mil as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

ProText Mobility Business Description

Address One West Las Olas Boulevard, Suite 500, Fort Lauderdale, FL, USA, 33301
ProText Mobility Inc is a Biotech Company developing a Hemp/CBD-Cannabis medicines platform for the legal cannabis industry, using proprietary live plant extraction processes and technologies. Protext has engaged in the research, testing, and development of bioavailable botanical products, all-natural ingredients formulated for nutraceuticals and pharmaceutical applications through proprietary live plant extraction technology.